Double Blind Placebo-Controlled Trial of Galantamine for Methadone-Maintained Individuals with Cocaine Use Disorder: Secondary Analysis of Effects on Illicit Opioid Use | June 2019

Articles (Manuscripts-Versions)

PubMed Central>American Journal on Addictions

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078084/

Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer’s Disease | May 2019

Articles

Frontiers in Neuroscience

https://www.frontiersin.org/articles/10.3389/fnins.2019.00472/full

Galantamine-Memantine Combination Superior to Donepezil-Memantine Combination in Alzheimer’s Disease: Critical Dissection with an Emphasis on Kynurenic Acid and Mismatch Negativity | February 2018

Articles (Manuscripts-Versions)

PubMed Central>Journal of Geriatric Care and Research

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457262/

Potential Role of Antipsychotic-Galantamine-Memantine Combination in the Treatment of Positive, Cognitive, and Negative Symptoms of Schizophrenia | November 2018

Articles

Molecular Neuropsychiatry

https://www.karger.com/Article/FullText/494495

The Clinical and Cost-Effectiveness of Donepezil, Rivastigmine, Galantamine and Memantine for Alzheimer’s Disease | January 2006

Publications (Books-Reports)

National Institute for Health Research

https://doi.org/10.3310/hta10010

Galantamine Improves Sustained Attention in Chronic Cocaine Users | February 2011

Articles (Manuscripts-Versions)

PubMed Central>Experimental and Clinical Psychopharmacology

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350372/

Donepezil, Galantamine, Rivastigmine and Memantine for the Treatment of Alzheimer’s Disease | June 2018

Publications (Guidelines)

National Institute for Health and Care Excellence

https://www.nice.org.uk/guidance/ta217

Efficacy and Safety of Donepezil, Galantamine, and Rivastigmine for the Treatment of Alzheimer’s Disease: A Systematic Review and Meta-Analysis | June 2008

Articles

NCBI>Clinical Interventions in Aging

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2546466/

Emergent Complications Following Donepezil Switchover to Galantamine in Three Cases of Dementia with Lewy Bodies | November 2005

Articles

Journal of Neurospychiatry and Clinical Neurosciences

https://neuro.psychiatryonline.org/article.aspx?articleid=102026

The Effect of Galantamine on Brain Atrophy Rate in Subjects with Mild Cognitive Impairment Is Modified by Apolipoprotein E Genotype: Post-Hoc Analysis of Data from a Randomized Controlled Trial | July 2014

Articles

Alzheimer’s Research and Therapy

https://alzres.biomedcentral.com/articles/10.1186/alzrt275

Galantamine Treatment in Alzheimer’s Disease: Response and Long-Term Outcome in a Routine Clinical Setting | September 2011

Articles

Neuropsychiatric Disease and Treatment

https://doi.org/10.2147/NDT.S24196

Pre-Sleep Treatment with Galantamine Stimulates Lucid Dreaming: A Double-Blind, Placebo-Controlled, Crossover Study | August 2018

Articles

PLOS ONE

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0201246

Combined Treatment with Memantine and Galantamine-CR Compared with Galantamine-CR Only in Antidementia Drug Naive Patients with Mild-to-Moderate Alzheimer’s Disease | October 2015

Articles

Alzheimer’s and Dementia: Translational Research and Clinical Interventions

https://www.sciencedirect.com/science/article/pii/S2352873715000268

Galantamine-Curcumin Hybrids as Dual-Site Binding Acetylcholinesterase Inhibitors | July 2020

Articles

Molecules

https://www.mdpi.com/1420-3049/25/15/3341

Metabolic Patterns Associated with the Clinical Response to Galantamine Therapy: A Fludeoxyglucose F 18 Positron Emission Tomographic Study | May 2005

Articles

JAMA Neurology

https://jamanetwork.com/journals/jamaneurology/fullarticle/788335

Effects of Risperidone and Galantamine Treatment on Alzheimer Biomarker Levels in Cerebrospinal Fluid | March 2017

Articles (Manuscripts-Versions)

PubMed Central>Journal of Alzheimer’s Disease

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203339/

Effects of Galantamine in Alzheimer’s Disease: Double-Blind Withdrawal Studies Evaluating Sustained versus Interrupted Treatment | November 2011

Articles

Current Alzheimer Research

http://www.eurekaselect.com/88937/article

Economic and Clinical Benefits of Galantamine in the Treatment of Mild to Moderate Alzheimer’s Disease in a Korean Population: A 52-Week Prospective Study | February 2008

Articles

Journal of Korean Medical Science

http://dx.doi.org/10.3346/jkms.2008.23.1.10

Long-Term Response to Galantamine in Relation to Short-Term Efficacy Data: Pooled Analysis in Patients with Mild to Moderate Alzheimer’s Disease | March 2011

Articles

Current Alzheimer Research

http://www.eurekaselect.com/87746/article

Effect of Galantamine on Attention in Patients with Alzheimer’s Disease Combined with Cerebrovascular Disease | December 2016

Abstracts

Geriatrics and Gerontology International

https://onlinelibrary.wiley.com/doi/10.1111/ggi.12934

The Effects of Galantamine Treatment on Attention and Its Relationship with Cognition and Activities of Daily Living in Patients with Mild to Moderate Alzheimer’s Disease | January 2015

Articles

Journal of Clinical Neurology

http://www.thejcn.com/DOIx.php?id=10.3988/jcn.2015.11.1.66

Influence of Galantamine on Vasomotor Reactivity in Alzheimer’s Disease and Vascular Dementia Due to Cerebral Microangiopathy | October 2007

Articles

Stroke

https://www.ahajournals.org/doi/10.1161/strokeaha.107.492033

Pharmacological Aspects of the Acetylcholinesterase Inhibitor Galantamine | April 2011

Articles

Journal of Pharmacological Sciences

http://doi.org/10.1254/jphs.11R01CR

Two Galantamine Titration Regimens in Patients Switched from Donepezil | October 2011

Abstracts

Acta Neurologica Scandinavica

http://onlinelibrary.wiley.com/doi/10.1111/j.1600-0404.2011.01594.x/abstract

Galantamine: A Novel Cholinergic Drug with a Unique Dual Mode of Action for the Treatment of Patients with Alzheimer’s Disease | June 2002

Articles

CNS Drug Reviews

https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1527-3458.2002.tb00221.x

Changes in Electrophysiological Markers of Cognitive Control After Administration of Galantamine | July 2018

Articles

NeuroImage: Clinical

https://www.sciencedirect.com/science/article/pii/S2213158218302316

Double-Blind Placebo-Controlled Trial of Galantamine for Methadone-Maintained Individuals with Cocaine Use Disorder: Secondary Analysis of Effects on Illicit Opioid Use | June 2019

Abstracts

American Journal on Addictions

https://onlinelibrary.wiley.com/doi/10.1111/ajad.12904

A Novel Galantamine-Curcumin Hybrid as a Potential Multi-Target Agent against Neurodegenerative Disorders | March 2021

Articles

Molecules

https://www.mdpi.com/1420-3049/26/7/1865

The Effects of an Uninterrupted Switch from Donepezil to Galantamine without Dose Titration on Behavioral and Psychological Symptoms of Dementia in Alzheimer’s Disease | May 2014

Articles

Dementia and Geriatric Cognitive Disorders Extra

https://www.karger.com/Article/FullText/362871

Methylphenidate and Galantamine in Patients with Vascular Cognitive Impairment: The Proof-of-Principle Study STREAM-VCI | January 2020

Articles

Alzheimer’s Research and Therapy

https://alzres.biomedcentral.com/articles/10.1186/s13195-019-0567-z

A 12-Week, Double-Blind, Placebo-Controlled Trial of Galantamine Adjunctive Treatment to Conventional Antipsychotics for Cognitive Impairments in Chronic Schizophrenia | February 2005

Articles

Clinical Psychopharmacology and Neuroscience

http://www.cpn.or.kr/journal/view.html?uid=25

Efficacy Study of Galantamine in Possible Alzheimer’s Disease with or without Cerebrovascular Disease and Vascular Dementia in Thai Patients: A Slow-Titration Regimen | May 2006

Articles

International Journal of Clinical Practice

http://dx.doi.org/10.1111/j.1368-5031.2006.00892.x

Feasibility and Effects of Galantamine on Cognition in Humans with Cannabis Use Disorder | May 2019

Articles (Manuscripts-Versions)

PubMed Central>Pharmacology, Biochemistry, and Behavior

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545124/

Galantamine Treatment in Alzheimer’s Disease with Cerebrovascular Disease: Responder Analyses from a Randomized, Controlled Trial (GAL-INT-6) | September 2008

Articles (Manuscripts-Versions)

Munich University of Technology>Journal of Psychopharmacology

http://mediatum.ub.tum.de/node?id=1308067

Attenuated Mismatch Negativity in Attenuated Psychosis Syndrome Predicts Psychosis: Can Galantamine-Memantine Combination Prevent Psychosis? | June 2018

Articles

NCBI>Molecular Neuropsychiatry

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206967/

A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People with Schizophrenia | August 2017

Articles (Manuscripts-Versions)

PubMed Central>Journal of Clinical Psychopharmacology

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484721/

The Effects of Galantamine on Psychopathology in Chronic Stable Schizophrenia | March 2009

Articles (Manuscripts-Versions)

PubMed Central>Clinical Neuropharmacology

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049075/

Galantamine: Effect on Nicotinic Receptor Binding, Acetylcholinesterase Inhibition, and Learning | February 2001

Articles

NCBI>Proceedings of the National Academy of Sciences

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC29386/

Randomized Placebo-Controlled Trial of Galantamine in Individuals with Cocaine Use Disorder | August 2019

Articles (Manuscripts-Versions)

PubMed Central>Journal of Substance Abuse Treatment

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918721/

Galantamine Plasma Concentration and Cognitive Response in Alzheimer’s Disease | May 2019

Articles

PeerJ

https://peerj.com/articles/6887/

Clinical and Cost-Effectiveness of Donepezil, Rivastigmine and Galantamine for Alzheimer’s Disease | March 2001

Publications (Books-Reports)

National Institute for Health Research

https://doi.org/10.3310/hta5010

Efficacy of Galantamine on Cognition in Mild-to-Moderate Alzheimer’s Dementia After Failure to Respond to Donepezil | May 2016

Articles

Psychiatry Investigation

https://doi.org/10.4306/pi.2016.13.3.341

Reduction of Behavioral Disturbances and Caregiver Distress by Galantamine in Patients with Alzheimer’s Disease | March 2004

Articles

American Journal of Psychiatry

https://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.161.3.532

A Double Blind, Placebo-Controlled Pilot Study of Galantamine Augmentation of Antidepressant Treatment in Older Adults with Major Depression | June 2008

Articles (Manuscripts-Versions)

PubMed Central>International Journal of Geriatric Psychiatry

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407281/

QT Interval Prolongation and Torsades De Pointes with Donepezil, Rivastigmine and Galantamine | August 2020

Articles

Therapeutic Advances in Drug Safety

https://journals.sagepub.com/doi/full/10.1177/2042098620942416

Effects of Galantamine on Smoking Behavior and Cognitive Performance in Treatment-Seeking Smokers Prior to a Quit Attempt | June 2018

Articles (Manuscripts-Versions)

PubMed Central>Human Psychopharmacology: Clinical and Experimental

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168949/

Galantamine-Memantine Combination for Cognitive Impairments Due to Electroconvulsive Therapy, Traumatic Brain Injury, and Neurologic and Psychiatric Disorders: Kynurenic Acid and Mismatch Negativity Target Engagement | March 2018

Articles

Primary Care Companion for CNS Disorders

https://doi.org/10.4088/PCC.17nr02235

The Prediction of Response to Galantamine Treatment in Patients with Mild to Moderate Alzheimer’s Disease | February 2014

Articles

Current Alzheimer Research

http://www.eurekaselect.com/116821/article

Galantamine-ER for the Treatment of Mild-to-Moderate Alzheimer’s Disease | December 2009

Articles

Clinical Interventions in Aging

https://www.dovepress.com/galantamine-er-for-the-treatment-of-mild-to-moderate-alzheimerrsquos-d-peer-reviewed-article-CIA

Attainment of Treatment Goals by People with Alzheimer’s Disease Receiving Galantamine: A Randomized Controlled Trial | March 2006

Articles

Canadian Medical Association Journal

http://www.cmaj.ca/content/174/8/1099.full